Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. William Young

Adrenal Diseases · Mayo Clinic College of Medicine

View

Dr. Austin Baraki

Obesity Medicine · Vineyard Health

View

Dr. Maria Fleseriu

Neuroendocrinology · OHSU Hospital

View

Dr. Priya Jaisinghani

Obesity Medicine · NYU Langone

View

Dr. John Stafford

General Endocrinology · OSUMC

View

Dr. David Cohen

Thyroid · RU

View

Dr. Susan Spratt

Diabetes · Duke

View

Dr. Anupam Kotwal

Thyroid · UNMC

View

Dr. Farah Khan

Diabetes · UWMC

View

Dr. Michael Shanik

Diabetes · SBU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Cosyntropin Stimulation Testing is More Selective than Postoperative Day 1 Basal Cortisol for Diagnosing Secondary Adrenal Insufficiency After Unilateral Adrenalectomy.

    Jul 28, 2024DOI: 10.1245/s10434-024-15773-0Journal ArticleASO

    Written by: Sean JohnsonCatherine D ZhangPatrick T HanggeTina W F YenTahseen J ShaikKara DoffekJames W FindlingTy CarrollDouglas B EvansSophie Y DreamTracy S Wang

    Find these authors on Roon

    JF
    Dr. James Findling
    Adrenal Diseases · Froedtert

    Summary

    BACKGROUND: Secondary adrenal insufficiency (SAI) may occur in patients after unilateral adrenalectomy for adrenal-dependent hypercortisolism (HC) or primary aldosteronism (PA). This study aimed to assess whether postoperative day (POD) 1 basal cortisol was predictive of an abnormal cosyntropin stimulation test (CST) result and the need for glucocorticoid replacement (GR).METHODS: A retrospective review of consecutive patients who underwent unilateral adrenalectomy for HC, PA, or both between September 2014 and September 2022 was performed. On POD1, CST was performed for all the patients with HC, and before 2021 for all the patients with PA. The patients with an abnormal CST result were deemed at risk of SAI and discharged with GR. Receiver operating characteristic (ROC) curves were generated to evaluate the sensitivity (SN) and specificity (SP) of basal cortisol thresholds to predict an abnormal CST result.RESULTS: The patients underwent unilateral adrenalectomy for overt hypercortisolism (OH; n = 42), mild autonomous cortisol excess (MACE; n = 70), mixed PA/HC (n = 22), or PA (n = 73). On POD1, CST was performed for 152 patients (93% OH, 96% MACE,73% PA/HC, 41% PA), and 80 patients (53%) had SAI (67% OH, 55% MACE, 44% PA/HC, 33% PA). The SN and SP of a basal cortisol level of 10 µg/dL or lower to predict an abnormal CST were respectively 92% and 77% for OH, 94% and 73% for MACE, 100% and 85% for PA, and 100% and 67% for PA/HC. The optimal basal cortisol level for predicting an abnormal CST for patients with PA or PA/HC was 5 µg/dL or lower (SN/SP, 100%).CONCLUSIONS: After unilateral adrenalectomy for HC, PA, or mixed PA/HC, POD1 CST improved identification of patients at risk for SAI compared with basal cortisol levels alone. The authors recommend that POD1 CST be performed to determine the risk for SAI and the need for postoperative GR after unilateral adrenalectomy for patients with HC.
    JFDr. James Findling
    Leading Voice

    Dr. James Findling

    Endocrinology · Adrenal Diseases
    Froedtert Hospital
    jamesf
    Milwaukee, WI, USA